InvestorsHub Logo
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Live Updating
profile icon
mdstocks Free
06/10/19 9:47 AM
profile icon
MOCKBA Free
06/09/19 10:07 PM
profile icon
mdstocks Free
06/09/19 4:11 PM
profile icon
MOCKBA Free
06/09/19 11:10 AM
profile icon
mdstocks Free
06/08/19 5:02 PM
profile icon
kex0414 Free
06/08/19 4:28 PM
profile icon
mdstocks Free
06/08/19 4:17 PM
profile icon
kex0414 Free
06/08/19 3:50 PM
profile icon
kex0414 Free
06/08/19 3:05 PM
profile icon
Obelax Free
06/08/19 2:43 PM
profile icon
kex0414 Free
06/08/19 2:23 PM
profile icon
kex0414 Free
06/08/19 1:47 PM
profile icon
mdstocks Free
06/08/19 12:55 PM
profile icon
paps3 Free
06/08/19 10:37 AM
profile icon
Golden Cross PremiumMember
06/08/19 10:10 AM
profile icon
MOCKBA Free
06/06/19 12:34 PM
profile icon
MOCKBA Free
06/06/19 8:36 AM
profile icon
Diggie-HH Free
06/06/19 4:49 AM
profile icon
Sonic Boom Free
06/05/19 7:15 PM
profile icon
Sonic Boom Free
06/05/19 7:12 PM
profile icon
kex0414 Free
06/04/19 8:50 AM
profile icon
robertus Free
06/04/19 8:23 AM
profile icon
robertus Free
06/04/19 7:08 AM
profile icon
Imarket13 Free
06/03/19 5:29 PM
profile icon
MOCKBA Free
06/03/19 5:09 PM
profile icon
Diggie-HH Free
06/03/19 4:35 PM
profile icon
kex0414 Free
06/02/19 10:17 PM
profile icon
kex0414 Free
06/02/19 7:26 PM
profile icon
kex0414 Free
06/02/19 7:13 PM
profile icon
MOCKBA Free
05/31/19 5:40 PM
profile icon
MOCKBA Free
05/31/19 5:39 PM
profile icon
Diggie-HH Free
05/31/19 12:13 PM
profile icon
Lanceo Free
05/31/19 12:01 PM
profile icon
Sonic Boom Free
05/08/19 7:03 AM
profile icon
dirtydozen911 Free
04/01/19 7:29 PM
profile icon
MOCKBA Free
03/31/19 12:04 PM
profile icon
mdstocks Free
03/31/19 12:31 AM
profile icon
MOCKBA Free
03/30/19 10:08 AM
profile icon
kex0414 Free
03/29/19 3:23 PM
profile icon
kex0414 Free
03/29/19 2:42 PM
profile icon
knoxlube Free
03/11/19 3:46 PM
profile icon
0whammies Free
03/11/19 2:05 PM

Oncternal Therapeutics Inc (ONCT) RSS Feed

Followers
69
Posters
246
Posts (Today)
0
Posts (Total)
1461
Created
02/25/08
Type
Free
Moderators

GTx Inc. website

 

http://finance.yahoo.com/q/ks?s=GTXI

Charts and tec stuff

 

GTx, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecules
to treat cancer, osteoporosis and bone loss, muscle wasting, and other serious medical conditions in the United States. The
company markets FARESTON tablets for the treatment of metastatic breast cancer in postmenopausal women through wholesale
drug distributors. Its product candidates in clinical development include ACAPODENE, a selective estrogen receptor modulator,
which is in pivotal Phase III clinical trials for the treatment of multiple serious side effects of androgen deprivation therapy, for
advanced prostate cancer; and for the prevention of prostate cancer in high risk men with precancerous prostate lesions called
high grade prostatic intraepithelial neoplasia (PIN). The company also develops Ostarine, a selective androgen receptor modulator,
which is in phase IIb clinical trials for the treatment of cancer cachexia; and for chronic kidney disease, and end-stage renal disease.
In addition, GTx develops Andarine for the treatment of various medical conditions relating to muscle wasting and/or bone loss;
prostarine for the treatment of benign prostatic hyperplasia; and andromustine, an anticancer product candidate for hormone refractory
prostate cancer. It has collaborations with Hybritech, Inc.; diaDexus, Inc.; MacroArray Technologies, LLC; Onconome, Inc.; and
Gen-Probe, Incorporated to develop an accurate blood or urine test to detect high grade PIN. GTx also has a research and development,
and strategic collaboration with Merck & Co., Inc. for the development of selective androgen receptor modulators. The company was
founded in 1997 and is headquartered in Memphis, Tennessee.
 

Volume:
Day Range:
Last Trade Time:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
New Post